title: Topiramate and panic attacks in patients with borderline personality disorder.
authors.forename: E
authors.initials: E
authors.lastname: Clivaz
authors.forename: I
authors.initials: I
authors.lastname: Chauvet
authors.forename: D
authors.initials: D
authors.lastname: Zullino
authors.forename: M
authors.initials: M
authors.lastname: Niquille
authors.forename: S
authors.initials: S
authors.lastname: Maris
authors.forename: A
authors.initials: A
authors.lastname: Cicotti
authors.forename: C
authors.initials: C
authors.lastname: Lazignac
authors.forename: C
authors.initials: C
authors.lastname: Lazignac Coralie
authors.forename: C
authors.initials: C
authors.lastname: Damsa
mesh_terms: D000293:Adolescent; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001883:Borderline Personality Disorder / Q000150:complications*; D004632:Emergency Medical Services; D005260:Female; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000009:adverse effects*; D016584:Panic Disorder / Q000139:chemically induced* / Q000523:psychology*; D000077236:Topiramate
chemical_list: D014151:Anti-Anxiety Agents; D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose; D008140:Lorazepam